News from us and our partners

Tags

Topics

0 results

News
1 October, 2015
Dow AgroSciences, Synthace research collaboration to accelerate product development using high tech tools
News
29 September, 2015
Asceneuron raises CHF 30 million in a Series A financing round led by Sofinnova Partners
News
22 September, 2015
ObsEva Appoints Elke Bestel as Chief Medical Officer and Jean-Pierre Gotteland as Chief Scientific Officer
News
31 August, 2015
Mainstay Medical's ReActiv8-A trial shows positive CLBP data
News
10 July, 2015
Bio World Congress on Industrial Biotechnology
News
1 July, 2015
Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer
News
1 July, 2015
MISSION Therapeutics appoints Dr Colin Goddard to its Board of Directors
News
30 June, 2015
NuCana Appoints Martin J Birkhofer, M.D. as Chief Medical Officer
News
22 June, 2015
Mainstay Medical Strengthens Board with New Independent Director
News
1 June, 2015
Creabilis appoints Catherine Moukheibir as Chairman of its Board of Directors
News
29 May, 2015
Mainstay Medical Gains Approval to Start US Clinical Trial of ReActiv8®
News
20 May, 2015
Shockwave Medical Announces $40 Million in Funding for Novel Lithoplasty System to Treat Advanced Peripheral, Coronary Vascular and Aortic Valve Disease
News
4 May, 2015
Stentys' Next-Generation of Self-Apposing Stent System Receives CE Marking Ahead of Plan
News
28 April, 2015
Pixium Vision announces the publication of PRIMA results, a wireless subretinal implant, in Nature Medicine
News
27 April, 2015
MedDay reports positive pivotal Phase III study results with MD1003 in patients with Progressive Multiple Sclerosis
News
20 April, 2015
MedDay announces its pivotal Phase III study of MD1003 in patients with Progressive Multiple Sclerosis meets primary endpoint

Dow AgroSciences, Synthace research collaboration to accelerate product development using high tech tools

Asceneuron raises CHF 30 million in a Series A financing round led by Sofinnova Partners

ObsEva Appoints Elke Bestel as Chief Medical Officer and Jean-Pierre Gotteland as Chief Scientific Officer

Mainstay Medical's ReActiv8-A trial shows positive CLBP data

Bio World Congress on Industrial Biotechnology

Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer

MISSION Therapeutics appoints Dr Colin Goddard to its Board of Directors

NuCana Appoints Martin J Birkhofer, M.D. as Chief Medical Officer

Mainstay Medical Strengthens Board with New Independent Director

Creabilis appoints Catherine Moukheibir as Chairman of its Board of Directors

Mainstay Medical Gains Approval to Start US Clinical Trial of ReActiv8®

Shockwave Medical Announces $40 Million in Funding for Novel Lithoplasty System to Treat Advanced Peripheral, Coronary Vascular and Aortic Valve Disease

Stentys' Next-Generation of Self-Apposing Stent System Receives CE Marking Ahead of Plan

Pixium Vision announces the publication of PRIMA results, a wireless subretinal implant, in Nature Medicine

MedDay reports positive pivotal Phase III study results with MD1003 in patients with Progressive Multiple Sclerosis

MedDay announces its pivotal Phase III study of MD1003 in patients with Progressive Multiple Sclerosis meets primary endpoint